Used in research to study the role of the human cannabinoid receptor 2 (CB2) in inflammatory and neurodegenerative conditions. Shows potential in modulating immune responses without psychoactive effects, making it a candidate for developing treatments for chronic pain, multiple sclerosis, and other inflammation-related diseases. Also employed in positron emission tomography (PET) studies to visualize CB2 receptor distribution in tissues, aiding drug development and disease diagnosis.